Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Alvarenga-Nascimento (São Paulo, Brazil), A. De Brito Léia (Vargem Grande Paulista, Brazil), T. Santos (São PauloGrande Paulista, Brazil), K. Herculano (São PauloGrande Paulista, Brazil), S. Soares (São PauloGrande Paulista, Brazil), R. Da Palma (Barcelona , Spain), A. Ligeiro-Oliveira (São Paulo, Brazil). Photobiomodulation acting as an immunotherapeutic strategy for chronic obstructive diseases such as asthma and COPD. 2056

Member's Comments

No comment yet.

Related content which might interest you: Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2014; 44: 475-482 Year: 2014 Therapeutic responses in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Emerging anti-inflammatory strategies for COPD}, Source: Eur Respir J 2012; 40: 724-741 Year: 2012 The effect of statin therapy in patients with chronic obstructive airway disease Source: International Congress 2015 – COPD: notable points Year: 2015 Modulation of airway inflammation to prevent exacerbations of COPD Source: Eur Respir Rev 2005; 14: 78-82 Year: 2005 Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002 Self-management plans in exacerbations of COPD Source: Annual Congress 2006 - Exacerbation of COPD Year: 2006 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Cilomilast is efficacious in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 68s Year: 2003 Where current pharmacological therapies fall short in COPD: symptom control is not enough Source: Eur Respir Rev 2007; 16: 98-104 Year: 2007 Fenspiride as complementary anti-inflammatory agent in therapy of patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD management Year: 2011 Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly Source: Eur Respir J 2003; 21: 3S-9S Year: 2003 Additive benefits of tiotropium in asthmatics and in patients with asthma complicated chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 546s Year: 2007 Effects of an eHealth intervention promoting correct use of medication in patients with asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Remote monitoring of respiratory patients Year: 2021 Use of metoprolol succinate in patients with cardiovascular diseases associated with asthma or chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 502s Year: 2006 Prevention of exacerbations of COPD with pharmacotherapy Source: Eur Respir Rev 2009; 19: 119-126 Year: 2010